Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the neoadjuvant sitravatinib-plus-nivolumab study is displayed instead of a 403 error, with the study details, outcome measures, and documents visible.
    Difference
    51%
    Check dated 2026-11-08T18:52:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T18:41:38.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide banner announces changes to NIH terminology, including use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T20:33:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site’s footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:31:58.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:25:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study details and document links. This indicates the record is currently inaccessible due to access restrictions.
    Difference
    19%
    Check dated 2026-09-20T20:40:20.000Z thumbnail image

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.